Targeting Tumor Endothelial Cells by <scp>EGCG</scp> Using Specific Liposome Delivery System Inhibits Vascular Inflammation and Thrombosis
Our results indicate the anti-tumor potential of EGCG-MEND in normalizing the inflammatory immune microenvironment and inhibiting thrombosis by targeting TEC.
Authors
- Takashi Nakamura (ORCID: https://orcid.org/0000-0001-9019-1426)
- Hideyoshi Harashima (ORCID: https://orcid.org/0000-0002-1568-9547)
- Aya Matsuda
- Taisei Nakade
- Yasuhiro Hida (ORCID: https://orcid.org/0000-0003-1759-4215)
- Hideki Takekawa
- Kyoko Hida (ORCID: https://orcid.org/0000-0002-7968-6062)
- Nako Maishi (ORCID: https://orcid.org/0000-0003-0195-6162)
- Zi Jia
Institutions
- Fujita Health University (JP)
- Hokkaido University (JP)
- Hokkaido Pharmaceutical University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70462
- Citations
- 4
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Japan Agency for Medical Research and Development
- BIKEN Foundation
- Japan Society for the Promotion of Science
- Research Institute for Microbial Diseases, Osaka University